Details for Patent: 8,481,546
✉ Email this page to a colleague
Which drugs does patent 8,481,546 protect, and when does it expire?
Patent 8,481,546 protects ZAVZPRET and is included in one NDA.
This patent has thirty-six patent family members in twenty-nine countries.
Drugs Protected by US Patent 8,481,546
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | ZAVZPRET | zavegepant hydrochloride | SPRAY, METERED;NASAL | 216386-001 | Mar 9, 2023 | RX | Yes | Yes | 8,481,546 | ⤷ Subscribe | Y | Y | ADMINISTRATION OF ZAVEGEPANT FOR ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA | ⤷ Subscribe | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,481,546
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 080746 | ⤷ Subscribe | |||
| Australia | 2011233627 | ⤷ Subscribe | |||
| Brazil | 112012024785 | ⤷ Subscribe | |||
| Canada | 2794950 | ⤷ Subscribe | |||
| Chile | 2012002739 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
